Optum unveiled plans to buy the 230-member physician group in May 2017 for an undisclosed amount.
According to a Feb. 15 FTC notice, Optum received an early termination for the waiting period on its deal with Reliant before the statutory period expired. The FTC’s transaction size threshold for reporting proposed acquisitions and mergers is $84.4 million for 2018, and was $80.8 million a year before. This means Optum’s bid for Reliant is at least at the FTC’s $80 million threshold.
Reliant Medical Group is one of several physician groups Optum is adding to its portfolio. Optum will acquire DaVita Medical Group for approximately $4.9 billion in cash, adding nearly 300 medical clinics to its network. Optum also is merging with Deerfield, Ill.-based Surgical Care Affiliates.
More articles on payer issues:
UnitedHealth will advance its bundled payment initiatives: 3 things to know
38 New York hospitals get $24.2M in quality payments from Excellus BCBS
Humana takes $148M hit from workforce cuts in 2017
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
